中文 | English
Return
Total: 1 , 1/1
Show Home Prev Next End page: GO
Author:(Franklin MAYCA POZO)

1.Chemical screen identifies shikonin as a broad DNA damage response inhibitor that enhances chemotherapy through inhibiting ATM and ATR.

Fangfang WANG ; Sora JIN ; Franklin MAYCA POZO ; Danmei TIAN ; Xiyang TANG ; Yi DAI ; Xinsheng YAO ; Jinshan TANG ; Youwei ZHANG

Acta Pharmaceutica Sinica B 2022;12(3):1339-1350

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 1 , 1/1 Show Home Prev Next End page: GO